Singulex Secures $19.1 Million

Singulex Inc., a Hayward, Calif.-based developer of biomarker diagnostic systems, has raised $19.1 million in Series D funding. OrbiMed Advisors led the deal, and was joined by return backers Fisk Ventures, Prolog Ventures and Advantage Capital. The company has now raised just over $30 million in total VC funding since 2002. Its R&D facilities are in St. Louis.